Proceedings 16th International Parallel and Distributed Processing Symposium 2002
DOI: 10.1109/ipdps.2002.1016590
|View full text |Cite
|
Sign up to set email alerts
|

Monte carlo simulation of HIV-1 evolution in response to selection by antibodies

Abstract: The persistence of human immunodeficiency virus type 1 (HIV-1) infection may be in part attributed to its ability to evolve to evade neutralizing antibody (NAb) surveillance. We have tested the prediction that positive selection of V3 is positively correlated with the strength of a patient's NAb response by analyzing a data set containing both sequences from the principal neutralizing domain of HIV-1 (V3) and measures of the strength of the NAb responses of several patients. Only viral sequences from the patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…The rare exceptions to the ODE approach have been Monte Carlo approaches that include the stochasticity of HIV dynamics at both the epidemiological (BarthJones et al, 2000;Drusano et al, 2000;Gallop et al, 2002;Mode and Sleeman, 2002;Sale et al, 2002) and inhost levels (da Silva and Hughes, 2002;Kamina et al, 2001;Kousignian et al, 2003;Ruskin et al, 2002, Tan andWu, 1998;Tuckwell and Le Corfec, 1998). Drusano et al (2000) used a Monte Carlo simulation to examine the impact of dosing interval on the viral dynamics.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The rare exceptions to the ODE approach have been Monte Carlo approaches that include the stochasticity of HIV dynamics at both the epidemiological (BarthJones et al, 2000;Drusano et al, 2000;Gallop et al, 2002;Mode and Sleeman, 2002;Sale et al, 2002) and inhost levels (da Silva and Hughes, 2002;Kamina et al, 2001;Kousignian et al, 2003;Ruskin et al, 2002, Tan andWu, 1998;Tuckwell and Le Corfec, 1998). Drusano et al (2000) used a Monte Carlo simulation to examine the impact of dosing interval on the viral dynamics.…”
Section: Introductionmentioning
confidence: 99%
“…The simulation, however, can be easily modified to include different cell lifetime distributions, and a number of other biologically realistic effects such as accurate pharmacokinetics, complex adherence patterns, resistance mutations, etc. Because of the vast numbers of cells and virions involved, a detailed Monte Carlo approach such as ours has only recently become computationally feasible, using very large multiprocessor clusters (da Silva and Hughes, 2002).…”
Section: Introductionmentioning
confidence: 99%